550 related articles for article (PubMed ID: 31925567)
1. TRPV4 deletion protects heart from myocardial infarction-induced adverse remodeling via modulation of cardiac fibroblast differentiation.
Adapala RK; Kanugula AK; Paruchuri S; Chilian WM; Thodeti CK
Basic Res Cardiol; 2020 Jan; 115(2):14. PubMed ID: 31925567
[TBL] [Abstract][Full Text] [Related]
2. Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction.
Small EM; Thatcher JE; Sutherland LB; Kinoshita H; Gerard RD; Richardson JA; Dimaio JM; Sadek H; Kuwahara K; Olson EN
Circ Res; 2010 Jul; 107(2):294-304. PubMed ID: 20558820
[TBL] [Abstract][Full Text] [Related]
3. TRPV4 channels mediate cardiac fibroblast differentiation by integrating mechanical and soluble signals.
Adapala RK; Thoppil RJ; Luther DJ; Paruchuri S; Meszaros JG; Chilian WM; Thodeti CK
J Mol Cell Cardiol; 2013 Jan; 54():45-52. PubMed ID: 23142541
[TBL] [Abstract][Full Text] [Related]
4. Mechanosensitive transient receptor potential vanilloid 4 regulates
Gombedza F; Kondeti V; Al-Azzam N; Koppes S; Duah E; Patil P; Hexter M; Phillips D; Thodeti CK; Paruchuri S
FASEB J; 2017 Apr; 31(4):1556-1570. PubMed ID: 28073835
[TBL] [Abstract][Full Text] [Related]
5. TRPV4 channels regulate tumor angiogenesis via modulation of Rho/Rho kinase pathway.
Thoppil RJ; Cappelli HC; Adapala RK; Kanugula AK; Paruchuri S; Thodeti CK
Oncotarget; 2016 May; 7(18):25849-61. PubMed ID: 27029071
[TBL] [Abstract][Full Text] [Related]
6. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
7. Enhanced postmyocardial infarction fibrosis via stimulation of the transforming growth factor-beta-Smad2 signaling pathway: role of transient receptor potential vanilloid type 1 channels.
Huang W; Rubinstein J; Prieto AR; Wang DH
J Hypertens; 2010 Feb; 28(2):367-76. PubMed ID: 19887954
[TBL] [Abstract][Full Text] [Related]
8. Multiscale Analysis of Extracellular Matrix Remodeling in the Failing Heart.
Perestrelo AR; Silva AC; Oliver-De La Cruz J; Martino F; Horváth V; Caluori G; Polanský O; Vinarský V; Azzato G; de Marco G; Žampachová V; Skládal P; Pagliari S; Rainer A; Pinto-do-Ó P; Caravella A; Koci K; Nascimento DS; Forte G
Circ Res; 2021 Jan; 128(1):24-38. PubMed ID: 33106094
[TBL] [Abstract][Full Text] [Related]
9. Myocardin-related transcription factor-A: mending a broken heart.
Parmacek MS
Circ Res; 2010 Jul; 107(2):168-70. PubMed ID: 20651293
[No Abstract] [Full Text] [Related]
10. Exercise Training Alleviates Cardiac Fibrosis through Increasing Fibroblast Growth Factor 21 and Regulating TGF-β1-Smad2/3-MMP2/9 Signaling in Mice with Myocardial Infarction.
Ma Y; Kuang Y; Bo W; Liang Q; Zhu W; Cai M; Tian Z
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830222
[TBL] [Abstract][Full Text] [Related]
11. Deletion of Endothelial TRPV4 Protects Heart From Pressure Overload-Induced Hypertrophy.
Adapala RK; Katari V; Kanugula AK; Ohanyan V; Paruchuri S; Thodeti CK
Hypertension; 2023 Nov; 80(11):2345-2356. PubMed ID: 37702061
[TBL] [Abstract][Full Text] [Related]
12. Ectonucleoside triphosphate diphosphohydrolase-1 (CD39) impacts TGF-β1 responses: insights into cardiac fibrosis and function following myocardial infarction.
Novitskaya T; Nishat S; Covarrubias R; Wheeler DG; Chepurko E; Bermeo-Blanco O; Xu Z; Baer B; He H; Moore SN; Dwyer KM; Cowan PJ; Su YR; Absi TS; Schoenecker J; Bellan LM; Koch WJ; Bansal S; Feoktistov I; Robson SC; Gao E; Gumina RJ
Am J Physiol Heart Circ Physiol; 2022 Dec; 323(6):H1244-H1261. PubMed ID: 36240436
[TBL] [Abstract][Full Text] [Related]
13. Nogo-C regulates post myocardial infarction fibrosis through the interaction with ER Ca
Weng L; Jia S; Xu C; Ye J; Cao Y; Liu Y; Zheng M
Cell Death Dis; 2018 May; 9(6):612. PubMed ID: 29795235
[TBL] [Abstract][Full Text] [Related]
14. TRPV4 Mechanotransduction in Fibrosis.
Adapala RK; Katari V; Teegala LR; Thodeti S; Paruchuri S; Thodeti CK
Cells; 2021 Nov; 10(11):. PubMed ID: 34831281
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
Li Q; Xu Y; Li X; Guo Y; Liu G
Toxicol Lett; 2012 Jun; 211(2):91-7. PubMed ID: 22465603
[TBL] [Abstract][Full Text] [Related]
16. Matrix stiffness controls cardiac fibroblast activation through regulating YAP via AT
Niu L; Jia Y; Wu M; Liu H; Feng Y; Hu Y; Zhang X; Gao D; Xu F; Huang G
J Cell Physiol; 2020 Nov; 235(11):8345-8357. PubMed ID: 32239716
[TBL] [Abstract][Full Text] [Related]
17. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.
Landry NM; Rattan SG; Filomeno KL; Meier TW; Meier SC; Foran SJ; Meier CF; Koleini N; Fandrich RR; Kardami E; Duhamel TA; Dixon IMC
Basic Res Cardiol; 2021 Apr; 116(1):25. PubMed ID: 33847835
[TBL] [Abstract][Full Text] [Related]
18. TRPV4 regulates matrix stiffness and TGFβ1-induced epithelial-mesenchymal transition.
Sharma S; Goswami R; Zhang DX; Rahaman SO
J Cell Mol Med; 2019 Feb; 23(2):761-774. PubMed ID: 30450767
[TBL] [Abstract][Full Text] [Related]
19. Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis.
Kong P; Christia P; Saxena A; Su Y; Frangogiannis NG
Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1363-72. PubMed ID: 23997102
[TBL] [Abstract][Full Text] [Related]
20. Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart.
Miller CL; Cai Y; Oikawa M; Thomas T; Dostmann WR; Zaccolo M; Fujiwara K; Yan C
Basic Res Cardiol; 2011 Nov; 106(6):1023-39. PubMed ID: 22012077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
